Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands.
The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the cannabis sector.
Organigram reports that it cultivates and internally extracts THCV at its state-of-the-art Moncton facility, establishing itself as the sole licensed Canadian producer to undertake this process.
Reshaping Cannabis Experiences Through Strategic Investments
Megan McCrae, senior VP of marketing and communications at Organigram, emphasized the company's commitment to exceeding consumer expectations and reshaping the cannabis experience …